$0.07
12.46% yesterday
Nasdaq, Nov 25, 09:43 pm CET
ISIN
US0051111096
Symbol
AFIB

Acutus Medical Inc Stock price

$0.07
-0.08 53.43% 1M
+0.03 62.28% 6M
-0.13 63.35% YTD
-0.18 70.47% 1Y
-3.37 97.85% 3Y
-26.43 99.72% 5Y
-26.43 99.72% 10Y
Nasdaq, Closing price Mon, Nov 25 2024
+0.01 12.46%
ISIN
US0051111096
Symbol
AFIB
Sector

Key metrics

Market capitalization $2.21m
Enterprise Value $24.72m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 1.26
P/S ratio (TTM) P/S ratio 0.11
P/B ratio (TTM) P/B ratio negative
Revenue growth (TTM) Revenue growth 24.72%
Revenue (TTM) Revenue $19.66m
EBIT (operating result TTM) EBIT $-71.82m
Free Cash Flow (TTM) Free Cash Flow $-60.99m
Cash position $12.60m
EPS (TTM) EPS $-1.25
P/E forward negative
P/S forward 0.17
EV/Sales forward negative
Short interest 1.91%
Show more

Is Acutus Medical Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.

Acutus Medical Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

2 Analysts have issued a Acutus Medical Inc forecast:

2x Hold
100%

Analyst Opinions

2 Analysts have issued a Acutus Medical Inc forecast:

Hold
100%

Financial data from Acutus Medical Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '23
+/-
%
20 20
25% 25%
100%
- Direct Costs 32 32
5% 5%
162%
-12 -12
32% 32%
-62%
- Selling and Administrative Expenses 30 30
36% 36%
152%
- Research and Development Expense 24 24
22% 22%
122%
-66 -66
31% 31%
-335%
- Depreciation and Amortization 5.89 5.89
19% 19%
30%
EBIT (Operating Income) EBIT -72 -72
30% 30%
-365%
Net Profit -33 -33
62% 62%
-167%

In millions USD.

Don't miss a Thing! We will send you all news about Acutus Medical Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Acutus Medical Inc Stock News

Neutral
GlobeNewsWire
12 days ago
CARLSBAD, Calif., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (OTC: AFIB) today reported results for the third quarter and year-to-date of 2024.
Neutral
GlobeNewsWire
4 months ago
CARLSBAD, Calif., Aug. 08, 2024 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (OTC: AFIB) today reported results for the second quarter and year-to-date of 2024.

Company Profile

Acutus Medical, Inc. engages in the development of medical devices and electrophy equipment. It creates electrophysiological mapping systems for the treatment of cardiac arrhythmias, such as atrial fibrillation, and ventricular tachycardia. The company was founded by Randell L. Werneth and Christoph Scharf in 2011 and is headquartered in Carlsbad, CA.

Head office United States
CEO Takeo Mukai
Employees 233
Founded 2011
Website www.acutusmedical.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today